The DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index; none of the 43 sources its claims cite is checked for support yet.
The COMMD Family Regulates Plasma LDL Levels and Attenuates Atherosclerosis Through Stabilizing the CCC Complex in Endosomal LDLR Trafficking
Open accessAbstract
Rationale: COMMD (copper metabolism MURR1 domain)-containing proteins are a part of the CCC (COMMD–CCDC22 [coiled-coil domain containing 22]–CCDC93 [coiled-coil domain containing 93]) complex facilitating endosomal trafficking of cell surface receptors. Hepatic COMMD1 inactivation decreases CCDC22 and CCDC93 protein levels, impairs the recycling of the LDLR (low-density lipoprotein receptor), and increases plasma low-density lipoprotein cholesterol levels in mice. However, whether any of the other COMMD members function similarly as COMMD1 and whether perturbation in the CCC complex promotes atherogenesis remain unclear. Objective: The main aim of this study is to unravel the contribution of evolutionarily conserved COMMD proteins to plasma lipoprotein levels and atherogenesis. Methods and Results: Using liver-specific Commd1 , Commd6 , or Commd9 knockout mice, we investigated the relation between the COMMD proteins in the regulation of plasma cholesterol levels. Combining biochemical and quantitative targeted proteomic approaches, we found that hepatic COMMD1, COMMD6, or COMMD9 deficiency resulted in massive reduction in the protein levels of all 10 COMMDs. This decrease in COMMD protein levels coincided with destabilizing of the core (CCDC22, CCDC93, and chromosome 16 open reading frame 62 [C16orf62]) of the CCC complex, reduced cell surface levels of LDLR and LRP1 (LDLR-related protein 1), followed by increased plasma low-density lipoprotein cholesterol levels. To assess the direct contribution of the CCC core in the regulation of plasma cholesterol levels, Ccdc22 was deleted in mouse livers via CRISPR/Cas9-mediated somatic gene editing. CCDC22 deficiency also destabilized the complete CCC complex and resulted in elevated plasma low-density lipoprotein cholesterol levels. Finally, we found that hepatic disruption of the CCC complex exacerbates dyslipidemia and atherosclerosis in ApoE3*Leiden mice. Conclusions: Collectively, these findings demonstrate a strong interrelationship between COMMD proteins and the core of the CCC complex in endosomal LDLR trafficking. Hepatic disruption of either of these CCC components causes hypercholesterolemia and exacerbates atherosclerosis. Our results indicate that not only COMMD1 but all other COMMDs and CCC components may be potential targets for modulating plasma lipid levels in humans.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
The COMMD family stabilizes the CCC complex in hepatocytes, and loss of Commd1, Commd6, Commd9, or Ccdc22 reduces cell-surface LDLR/LRP1 and raises plasma LDL cholesterol. In ApoE3*Leiden mice, hepatic CCC inactivation exacerbates hyperlipidemia and accelerates aortic-root atherosclerosis.
Key findings
- Hepatic Commd6 knockout increased plasma total cholesterol by ≈37% on chow (P<0.01) and ≈40% on high-fat high-cholesterol diet (P<0.001), with increased LDL cholesterol and ApoB100; hepatic Commd9 ablation similarly increased plasma total cholesterol and ApoB100 (P<0.001).
- COMMD6 colocalized with WASH1, FAM21, COMMD1, and VPS35; COMMD6 deficiency reduced total and plasma-membrane LDLR and LRP1 in primary hepatocytes.
- COMMD6 silencing reduced COMMD1 protein without affecting COMMD1 mRNA; MG132 partially restored COMMD1. Hepatic Commd1 or Commd6 deletion reduced all COMMD proteins and CCC core subunits by ≈70% (P<0.05), increased WASH1 by ≈50% (P<0.05), while retromer, LDLR, and LRP1 were unaffected; Commd9 loss reduced CCC core similarly but COMMD1/2/3/6/8 only by 40%–50%.
- Liver CRISPR/Cas9 Ccdc22 editing reduced CCDC22 by ≈70%, lowered CCDC93/C16orf62/COMMD1, and raised plasma total cholesterol by ≈35% (P<0.01) via LDL cholesterol and ApoB100. In ApoE3*L;Commd1ΔHep mice fed HFC for 12 weeks, plasma total cholesterol and triglyceride rose ≈100% (P<0.001) and aortic-root lesion area was ≈50% larger (P<0.01); no aortic arch lesions were observed.
Methods
- Mouse models included liver-specific Commd1, Commd6, and Commd9 knockouts; adenoviral CRISPR/Cas9 Ccdc22 editing; ApoE3*Leiden mice; AAV-PCSK9-D377Y; and WT/Cas9 controls. Cell work used HEK293T, HepG2, Huh7, RAW264.7, and primary hepatocytes.
- Assays included plasma/liver cholesterol and triglyceride measurements, FPLC lipoprotein fractionation, Western blot, qRT-PCR, immunoprecipitation, sucrose gradients, targeted proteomics (QconCAT LC-MS), and atherosclerosis lesion histology/en face Oil Red O.
- Statistics used Student t test with P<0.05 considered significant; in vitro data were from 3 independent experiments, and mouse data show averages ± SEM with n=7–12 (some analyses n=4–11).
Limitations
- Stated in the paper: whether human genetic variants in COMMDs, CCDC93, and C16orf62 are associated with plasma lipid levels and cardiovascular events needs validation; the stoichiometry of heterogeneous CCC complexes and the relation between PCSK9-mediated LDLR degradation and CCC-dependent recycling require further study; a possible role for the CCC complex in SR-B1-mediated HDL cholesteryl ester uptake warrants further studies.
- Evident from the text: the findings rely on mouse liver-specific models and cultured cells rather than human cohorts, and some cited heterozygous-loss data are unpublished (B. van de Sluis, unpublished data, 2017).
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 of 43 cited sources checked · 0 supported · 0 flagged
- Findingown data
The integrity of the CCC complex is not exclusively controlled by COMMD1 but by numerous members of the COMMD family.
“We found that the integrity of the CCC complex is not exclusively controlled by COMMD1 but by numerous members of the COMMD family.”
Quote in the paperSubstantial claim - Findingown data
Plasma levels of ApoB100 were significantly elevated (P<0.01) in Commd6ΔHep mice, both on chow and HFC diet feeding.
“the plasma levels of ApoB100 were significantly elevated (P<0.01) in Commd6Δ Hep mice, both on chow and HFC diet feeding”
Quote in the paperSubstantial claim - Findingreasoning
The specific decrease in the CCC core components in all 3 models of hepatic COMMD deficiency coincides with elevated plasma cholesterol levels.
“This specific decrease in the CCC core components in all 3 models of hepatic COMMD deficiency coincides with elevated plasma cholesterol levels.”
Quote in the paperSubstantial claim - Findingown data
Ablation of COMMD6 impaired the total and plasma membrane expression of LRP1.
“Similar effect on the total and plasma membrane expression of LRP1 was seen”
Quote in the paperNot a substantial claim - Findingown data
The stability of the COMMDs in hepatocytes relies on the CCC core component CCDC22.
“we showed that the stability of the COMMDs in hepatocytes relies on the CCC core component CCDC22”
Quote in the paperSubstantial claim
- Findingown data
The further rise in plasma TC and ApoB48 levels was reflected by the marked change in plasma lipoprotein profile.
“This further rise in both plasma TC and ApoB48 levels was also reflected by the marked change in their plasma lipoprotein profile”
Quote in the paperNot a substantial claim - Findingown data
COMMD1 and COMMD6 are physically associated with each other, as determined by coimmunoprecipitation assay.
“we observed that COMMD1 and COMMD6 are physically associated with each other, as determined by coimmunoprecipitation assay”
Quote in the paperSubstantial claim - Findingown data
CCDC22 inactivation increased plasma TC levels by ≈35% (P<0.01) compared with WT mice injected with Ad-gRNA_Ccdc22.
“it increased plasma TC levels by ≈35% (P<0.01)compared with WT mice injected with Ad-gRNA_Ccdc22”
Quote in the paperSubstantial claim - Findingown data
Hepatic ablation of both LDLR and COMMD1 further increased ApoB48 levels compared with control animals.
“hepatic ablation of both LDLR and COMMD1 further increased ApoB48 levels compared with control animals”
Quote in the paperSubstantial claim - Findingown data
COMMD3 protein levels were only decreased by ≈50% (P<0.05) in Commd1 and Commd6 knockout livers compared with WT livers.
“COMMD3 protein levels were only decreased by ≈50% (P<0.05).”
Quote in the paperSubstantial claim - Findingown data
Inactivation of the CCC complex in mouse livers leads to reduced cell surface levels of LDLR and LRP1.
“inactivation of the CCC complex in mouse livers leads to reduced cell surface levels of LDLR and LRP1 (LDLR-related protein 1)”
Quote in the paperSubstantial claim - Findingown data
Targeting Ccdc22 significantly reduced the expression of all COMMD proteins, with the exception of COMMD6.
“Targeted proteomics analysis showed that the expression of all COMMD proteins was significantly reduced by targeting Ccdc22, with the exception of COMMD6”
Quote in the paperSubstantial claim - Findingown data
LDLR deficiency led to a significant increase in plasma TC and triglyceride in WT mice.
“LDLR deficiency led to a significant increase in plasma TC and triglyceride (Figure 6B) in WT mice.”
Quote in the paperSubstantial claim - Findingown data
The effect of hepatic Commd1 deletion on COMMD protein amounts was similar to Commd6 depletion.
“The effect of hepatic Commd1 deletion on COMMD protein amounts was similar to Commd6 depletion”
Quote in the paperNot a substantial claim - Findingown data
The CCC core subunits were reduced by ≈70% (P<0.05) in COMMD1- and COMMD6-deficient livers.
“the CCC core subunits were reduced by ≈70% (P<0.05) in COMMD1-and COMMD6-deficient livers”
Quote in the paperSubstantial claim - Findingown data
The dramatic increase in ApoB48 in mice deficient for both COMMD1 and LDLR is supported by targeted proteomics analysis.
“This dramatic increase in ApoB48 in mice deficient for both COMMD1 and LDLR is supported by targeted proteomics analysis”
Quote in the paperNot a substantial claim - Findingown data
The expression of the WASH component WASH1 was increased by ≈50% (P<0.05) after loss of COMMD1 or COMMD6.
“the expression of the WASH component WASH1 was increased by ≈50% (P<0.05) after loss of COMMD1 or COMMD6.”
Quote in the paperNot a substantial claim - Findingown data
Hepatic COMMD1 deficiency results in a dramatic rise in plasma total cholesterol and triglyceride levels (≈100% increase; P<0.001) in ApoE3*L mice fed a HFC diet for 12 weeks.
“but resulted in a dramatical rise in plasma TC and triglyceride levels (≈100% increase; P<0.001; Figure 7A).”
Quote in the paperSubstantial claim - Findingown data
Inactivation of the CCC complex in mouse livers is accompanied by increased plasma LDL cholesterol levels.
“accompanied by increased plasma low-density lipoprotein cholesterol levels.”
Quote in the paperSubstantial claim - Findingown data
The partial reduction in COMMD1 and COMMD6 levels was confirmed by Western blot analysis.
“This partial reduction in COMMD1 and COMMD6 levels was confirmed by Western blot analysis”
Quote in the paperNot a substantial claim - Findingown data
The lipoprotein profile of WT and Commd6ΔHep animals fed a chow or HFC diet showed an increase in plasma LDL cholesterol in Commd6 knockout animals.
“the lipoprotein profile of WT and Commd6Δ Hep animals fed a chow or HFC diet (Figure 1C and 1D; Online Figure IID and IIE) showed an increase in plasma LDL cholesterol in Commd6 knockout animals.”
Quote in the paperSubstantial claim - Findingown data
Hepatic Commd1 and Commd6 depletion in mice significantly reduced the expression of all COMMD proteins.
“hepatic Commd1 and Commd6 depletion in mice significantly reduced the expression of all COMMD proteins”
Quote in the paperSubstantial claim - Findingown data
PCSK9-D377Y expression blunted the protein expression of LDLR, but not LRP1, in the liver of WT and Commd1ΔHep mice.
“PCSK9-D377Y expression blunted the protein expression of LDLR, but not LRP1, in the liver of WT and Commd1Δ Hep mice”
Quote in the paperNot a substantial claim - Findingown data
Hepatic COMMD1 deficiency does not affect total protein expression of LDLR and LRP1 in the liver of ApoE3*L mice fed a HFC diet for 12 weeks.
“Hepatic COMMD1 deficiency did not affect the total protein expression of LDLR and LRP1 in the liver of ApoE3*L (Online Figure VIIIA) mice fed a HFC diet for 12 weeks”
Quote in the paperSubstantial claim - Findingown data
COMMD6 strongly colocalizes with WASH1, FAM21, and COMMD1, almost to a similar degree as seen between COMMD1 and WASH1 and FAM21.
“Immunofluorescence staining showed that COMMD6 strongly colocalizes with WASH1, FAM21, and COMMD1, almost to a similar degree as seen between COMMD1 and WASH1 and FAM21”
Quote in the paperSubstantial claim - Findingown data
Silencing of COMMD1 did not reduce COMMD6 protein levels.
“However, silencing of COMMD1 did not reduce COMMD6 protein levels”
Quote in the paperSubstantial claim - Findingown data
Blocking proteasome activity partially restored COMMD1 protein levels in COMMD6 knockdown cell lines.
“Blocking proteasome activity partially restored COMMD1 protein levels in COMMD6 knockdown cell lines”
Quote in the paperSubstantial claim - Findingown data
Animals lacking both COMMD1 and LDLR showed higher increase in plasma TC and triglyceride levels compared with mice only deficient for LDLR in the liver.
“Animals that lack the protein expression of both COMMD1 and LDLR showed higher increase in plasma TC and triglyceride levels compared with mice only deficient for LDLR in the liver”
Quote in the paperSubstantial claim - Findingown data
COMMD6 overlapped with VPS35 almost to the same extent as COMMD1 and VPS35.
“COMMD6 overlapped with VPS35 almost to the same extent as COMMD1 and VPS35”
Quote in the paperNot a substantial claim - Findingown data
LDLR deficiency resulted in a marked increase in both ApoB100 and ApoB48.
“LDLR deficiency resulted in a marked increase in both apolipoproteins”
Quote in the paperNot a substantial claim - Findingown data
Ablation of Commd9 reduced the expression of the CCC complex subunits CCDC22, CCDC93, and C16orf62 (P<0.05) to a similar extent as COMMD1 or COMMD6 inactivation.
“Ablation of Commd9 reduced the expression of the CCC complex subunits CCDC22, CCDC93, and C16orf62 (P<0.05) to a similar extent as COMMD1 or COMMD6 inactivation”
Quote in the paperSubstantial claim - Findingown data
The expression of the retromer subunits, LDLR and LRP1, were unaffected in COMMD1- and COMMD6-deficient livers.
“whereas the expression of the retromer subunits, LDLR and LRP1, were unaffected”
Quote in the paperSubstantial claim - Findingown data
Hepatic deficiency of both COMMD1 and LDLR led to a large increase of plasma lipoproteins in the chylomicron remnant/very-low-density lipoprotein and LDL size range.
“Hepatic deficiency of both COMMD1 and LDLR led to a large increase of plasma lipoproteins in the chylomicron remnant/very-low-density lipoprotein and LDL size range.”
Quote in the paperSubstantial claim - Findingown data
Hepatic inactivation of the CCC complex accelerates atherosclerosis in a mouse model with a human-like lipoprotein profile.
“Hepatic inactivation of the CCC complex accelerates atherosclerosis in a mouse model with a human-like lipoprotein profile.”
Quote in the paperSubstantial claim - Findingown data
Silencing COMMD6 in HepG2 and Huh7 cells produced similar effects as described above.
“we also silenced COMMD6 in the hepatocellular carcinoma cell lines HepG2 and Huh7 and found similar effects as described above”
Quote in the paperNot a substantial claim - Findingown data
COMMD9 seems to be less essential for COMMD stability, because COMMD1, 2, 3, 6, and 8 expression were only reduced by 40% to 50% (P<0.05) after Commd9 depletion.
“COMMD9 seems to be less essential for COMMD stability, because COMMD1, 2, 3, 6, and 8 expression were only reduced by 40% to 50% (P<0.05)after Commd9 depletion”
Quote in the paperSubstantial claim - Findingown data
The rise in plasma cholesterol levels coincides with ≈50% larger atherosclerotic lesion area (P<0.01) in the aortic root of ApoE3*L;Commd1ΔHep mice.
“This rise in plasma cholesterol levels coincided with ≈50% larger atherosclerotic lesion area (P<0.01) in the aortic root of these animals (Figure 7C and 7D).”
Quote in the paperSubstantial claim - Findingown data
All COMMD and CCC core proteins interact with COMMD1 in mouse primary hepatocytes.
“We found that all COMMD and CCC core proteins interact with COMMD1 (Figure 4B).”
Quote in the paperSubstantial claim - Findingown data
The decreased COMMD1, CCDC22, and CCDC93 levels were not caused by aberrant gene expression.
“The decreased COMMD1, CCDC22, and CCDC93 levels were not caused by aberrant gene expression”
Quote in the paperSubstantial claim - Findingown data
The degree of dependency differs between COMMD proteins; for example, COMMD5 and COMMD10 are reduced by ≈70%, whereas COMMD3 is only diminished by 50% on Commd1, Commd6, or Commd9 depletion.
“For example, COMMD5 and COMMD10 are reduced by ≈70%, whereas COMMD3 is only diminished by 50% on Commd1, Commd6, or Commd9 depletion.”
Quote in the paperNot a substantial claim - Findingown data
Hepatic CRISPR/Cas9-mediated Ccdc22 editing increases plasma cholesterol levels.
“Hepatic CRISPR/Cas9-mediated Ccdc22 editing increases plasma cholesterol levels.”
Quote in the paperSubstantial claim - Findingown data
No atherosclerotic lesions were observed in the aortic arch of both ApoE3*L and ApoE3*L;Commd1ΔHep mice.
“We observed no atherosclerotic lesions in the aortic arch of both genotypes (Online Figure VIIIB),”
Quote in the paperNot a substantial claim - Findingown data
Only the fraction of COMMD3 proteins associated with the CCC and WASH complexes is adversely affected after Commd1 deletion.
“our cell fractionation experiments showed that only the fraction of COMMD3 proteins associated with the CCC and WASH complexes are adversely affected after Commd1 deletion.”
Quote in the paperNot a substantial claim - Findingown data
Hepatic Commd deletion perturbs the protein stability of the complete COMMD family.
“Hepatic Commd deletion perturbs the protein stability of the complete COMMD (copper metabolism MURR1 domain) family.”
Quote in the paperSubstantial claim - Findingown data
The expression of COMMD proteins in hepatocytes relies on each other.
“This study shows also for the first time that the expression of the COMMD proteins in hepatocytes relies on each other, but intriguingly, the degree of dependency differs between COMMD proteins.”
Quote in the paperSubstantial claim - Findingreasoning
Perturbation in the CCC complex contributes to the progression of atherosclerosis in ApoE3*L mice, a mouse model with a human-like lipoprotein profile.
“In addition, we found that perturbation in the CCC complex contributes in the progression of atherosclerosis in ApoE3*L mice, a mouse model with a human-like lipoprotein profile.”
Quote in the paperSubstantial claim - Findingown data
Loss of CCC core subunits is correlated with elevated plasma LDL cholesterol levels in all our models.
“This loss of the CCC core subunits was correlated with elevated plasma LDL cholesterol levels in all our models, 8 indicating that specific disruption of the CCC core leads to the hypercholesterolemic phenotype.8,11”
Quote in the paperSubstantial claim - Findingown data
The integrity of the CCC core components CCDC22, CCDC93, and C16orf62 is not exclusively controlled by COMMD1 but by numerous members of the COMMD family.
“In this study, we revealed that the integrity of the CCC core components, namely, CCDC22, CCDC93 and C16orf62, is not exclusively controlled by COMMD1, 8 but by numerous members of the COMMD family (Online Figure IX).”
Quote in the paperSubstantial claim - Findingown data
The stability of COMMDs in hepatocytes relies on the CCC core component CCDC22.
“In addition, our data also suggest that the stability of the COMMDs in hepatocytes relies on the CCC core component CCDC22, indicating a strong interrelation between the COMMD family and the core of the CCC complex in endosomal trafficking of cell surface receptors, including LDLR and LRP1.8”
Quote in the paperSubstantial claim - Findingown data
COMMD6 inactivation downregulates COMMD1 in different cell lines.
“COMMD6 (copper metabolism MURR1 domain 6) inactivation downregulates COMMD1 in different cell lines.”
Quote in the paperNot a substantial claim - Findingcitation
In addition to COMMD1, COMMD3 and COMMD6 are associated with the WASH complex.
“We now show that in addition to COMMD1, also COMMD3 and COMMD6 are associated with the WASH complex.9”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [9]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingown data
Depletion of either COMMD1 or COMMD9 perturbs the formation of the CCC complex.
“Depletion of either COMMD1 (copper metabolism MURR1 domain 1) or COMMD9 perturbs the formation of the CCC (COMMD-CCDC22-CCDC93) complex.”
Quote in the paperSubstantial claim - Findingown data
Hepatic ablation of Commd1 and Commd6 in mice fed a chow diet leads to elevated plasma high-density lipoprotein cholesterol levels.
“Interestingly, our data show that hepatic ablation of Commd1 8 and Commd6 in mice fed a chow diet also lead to elevated plasma high-density lipoprotein cholesterol levels.”
Quote in the paperNot a substantial claim - Findingreasoning
Hepatic CCC deficiency reduces surface levels of LDLR and LRP1.
“Although the total protein levels of hepatic LDLR and LRP1 in WT and ApoE3*L mice are not affected on CCC inactivation, this study and our previous work 8 showed that hepatic CCC deficiency reduces surface levels of LDLR and LRP1-likely because of impaired endosomal receptor trafficking 8 -leading to increased plasma LDL cholesterol levels and accelerated atherosclerosis (Online Figure IX).”
Quote in the paperSubstantial claim - Findingown data
CCC complex inactivation further increases dyslipidemia in hepatic LDLR-deficient mice.
“CCC (COMMD-CCDC22-CCDC93) complex inactivation further increases dyslipidemia in hepatic LDLR (low-density lipoprotein receptor)-deficient mice.”
Quote in the paperSubstantial claim - Findingown data
Hepatic COMMD6 deficiency increases plasma cholesterol levels.
“Hepatic COMMD6 (copper metabolism MURR1 domain 6) deficiency increases plasma cholesterol levels.”
Quote in the paperSubstantial claim - Study design and conductown data
These proteins were not detected in IgG negative control immunoprecipitates.
“These proteins were not detected in IgG negative control immunoprecipitates.”
Quote in the paperSubstantial claim - Interpretationreasoning
COMMD6 may also participate in the CCC-WASH axis in endosomal sorting of receptors, including LDLR and LRP1.
“suggest that COMMD6 may also participate in the CCC-WASH axis in endosomal sorting of receptors, including LDLR and LRP1.”
Quote in the paperNot a substantial claim - Interpretationown data
The integrity of the CCC complex relies on the expression of all members of the COMMD family.
“and that the integrity of the CCC complex relies on the expression of all members of the COMMD family.”
Quote in the paperSubstantial claim - Interpretationown data
COMMD1 instability is partially ubiquitin dependent.
“suggesting that COMMD1 instability is partially ubiquitin dependent.”
Quote in the paperNot a substantial claim - Interpretationcitation
The reduced total LDLR and LRP1 levels can likely be explained by increased lysosomal degradation because of impaired receptor recycling, similar as seen in WASH1-deficient mouse fibroblast cells.
“The reduced total LDLR and LRP1 levels can likely be explained by increased lysosomal degradation because of impaired receptor recycling, similar as seen in WASH1-deficient mouse fibroblast cells.8,26”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [8]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [26]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationcitation
The CCC complex also facilitates the functioning of LRP1.
“A similar increase in plasma ApoB48 levels and change in lipoprotein profile has been seen on hepatic depletion of both Ldlr and Lrp1, 28 suggesting that the CCC complex also facilitates the functioning of LRP1.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [28]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationown data
COMMD6 forms a protein complex with COMMD1 that is indispensable for the protein stability of CCC complex in endosomal receptor recycling.
“These data indicate that COMMD6 form a protein complex with COMMD1 that is indispensable for the protein stability of CCC complex in endosomal receptor recycling.”
Quote in the paperSubstantial claim - Interpretationreasoning
This study assigns a large number of candidate genes controlling plasma LDL cholesterol levels.
“This study assigns a large number of candidate genes controlling plasma low-density lipoprotein cholesterol levels”
Quote in the paperSubstantial claim - Interpretationown data
The CCC complex facilitates the endosomal trafficking of several members of the LDLR family.
“implying that the CCC complex facilitates the endosomal trafficking of several members of the LDLR family.”
Quote in the paperSubstantial claim - Interpretationown data
The stability of the CCC core components (CCDC22, CCDC93, and C16orf62) seems to be entirely dependent on the COMMD proteins.
“In contrast, the stability of the CCC core components (CCDC22, CCDC93, and C16orf62) seems to be entirely dependent on the COMMD proteins.”
Quote in the paperSubstantial claim - Interpretationown data
Proper formation of the core of the CCC complex in hepatocytes is required to control plasma LDL cholesterol levels.
“In summary, these results indicate that proper formation of the core of the CCC complex in hepatocytes is required to control plasma LDL cholesterol levels.”
Quote in the paperSubstantial claim - Interpretationown data
The reduced surface levels of both LDLR and LRP1 on inactivation of the CCC complex suggest that the CCC complex orchestrates the trafficking of both receptors.
“The reduced surface levels of both LDLR and LRP1 on inactivation of the CCC complex (Online Figure VB) suggest that the CCC complex orchestrate the trafficking of both receptors.”
Quote in the paperSubstantial claim - Premisecitation
The CCC complex localizes to endosomes through physical association with the WASH complex.
“The CCC complex localizes to endosomes through physical association with the WASH (Wiskott-Aldrich syndrome protein and SCAR homologue) complex.9”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [9]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
COMMD1 is assembled into the CCC complex together with C16orf62 and the coiled-coil proteins CCDC22 and CCDC93.
“COMMD1 is assembled into the CCC (COMMD-CCDC22 [coiled-coil domain containing 22]-CCDC93 [coiled-coil domain containing 93]) complex together with chromosome 16 open reading frame 62 (C16orf62) and the coiled-coil proteins CCDC22 and CCDC93.9”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [9]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationown data
Hepatic Commd6 ablation causes hypercholesterolemia, similar to Commd1.
“these data demonstrate that, similar to Commd1 8 , hepatic Commd6 ablation causes hypercholesterolemia.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [8]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationown data
The endosomal trafficking of LDLR and LRP1 in clearing ApoB-containing particles is dependent on the CCC complex.
“Overall, our studies suggest that the endosomal trafficking of LDLR and LRP1 in clearing ApoB-containing particles are dependent on the CCC complex”
Quote in the paperSubstantial claim - Premisecitation
Because LDLR can compensate for the loss of LRP1, studying LRP1 functioning in the clearance of plasma ApoE- and ApoB-containing particles in mice is only possible in a hepatic LDLR-deficient background.
“Because LDLR can compensate for the loss of LRP1, studying LRP1 functioning in the clearance of plasma ApoEand ApoB-containing particles in mice is only possible in a hepatic LDLR-deficient background.28”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [28]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationown data
The main disturbance of COMMD3 levels on COMMD1 deficiency is on the fraction of COMMD3 that is associated with the CCC and WASH complexes and LDLR.
“These results suggest that the main disturbance of COMMD3 levels on COMMD1 deficiency is on the fraction of COMMD3 that is associated with the CCC and WASH complexes and LDLR.”
Quote in the paperSubstantial claim - Premisecitation
Recruitment of the CCC and WASH complexes to endosomes is dependent on the retromer subunit VPS35.
“The recruitment of the CCC and WASH complexes to the endosomes is dependent on the retromer subunit VPS35.8,9,12”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [8]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [9]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [12]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
Clearing circulating atherogenic LDL cholesterol is highly dependent on the LDLR in hepatocytes.
“C learing circulating atherogenic low-density lipoprotein (LDL) cholesterol is highly dependent on the LDLR (LDL receptor) in hepatocytes.1,2”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [1]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [2]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationown data
The CCC complex facilitates endosomal trafficking of LDLR and LRP1.
“The CCC complex facilitates endosomal trafficking of LDLR and LRP1.”
Quote in the paperSubstantial claim - Interpretationreasoning
Hepatic perturbations in the CCC complex exacerbate hyperlipidemia in ApoE3*L mice.
“Taken together, hepatic perturbations in the CCC complex exacerbates hyperlipidemia-likely because of a defect in LDLR and LRP1-mediated lipoprotein clearanceand accelerates atherosclerosis in ApoE3*L mice.”
Quote in the paperSubstantial claim - Interpretationown data
Hepatic perturbations in the CCC complex accelerate atherosclerosis in ApoE3*L mice.
“Taken together, hepatic perturbations in the CCC complex exacerbates hyperlipidemia-likely because of a defect in LDLR and LRP1-mediated lipoprotein clearanceand accelerates atherosclerosis in ApoE3*L mice.”
Quote in the paperSubstantial claim - Interpretationown data
C16orf62 participates in the CCC complex.
“This is an interesting observation, as our study implies that C16orf62 does participate in the CCC complex because ablation of either Ccdc22 or a Commd gene leads to a dramatic reduction in C16orf62 levels.”
Quote in the paperSubstantial claim - Interpretationown data
Atherogenesis did not yet develop in the aortic arch of these mice.
“indicating that atherogenesis did not yet develop in this part of the aorta.”
Quote in the paperNot a substantial claim - Interpretationcitation
The reduction in surface levels of LDLR and LRP1 by hepatic CCC deficiency is likely because of impaired endosomal receptor trafficking.
“Although the total protein levels of hepatic LDLR and LRP1 in WT and ApoE3*L mice are not affected on CCC inactivation, this study and our previous work 8 showed that hepatic CCC deficiency reduces surface levels of LDLR and LRP1-likely because of impaired endosomal receptor trafficking 8 -leading to increased plasma LDL cholesterol levels and accelerated atherosclerosis (Online Figure IX).”
Quote in the paperSubstantial claim - Interpretationown data
CCDC22 insufficiency directly causes high plasma LDL cholesterol levels in X-linked intellectual disability patients.
“Now, we provide genetic evidence that CCDC22 insufficiency directly cause high plasma LDL cholesterol levels in X-linked intellectual disability patients and establish that CCC complex-mediated LDLR trafficking is conserved between mice and humans.”
Quote in the paperSubstantial claim - Interpretationown data
The portion of the COMMDs assembled into the CCC complexes is particularly disturbed by removal of another COMMD protein.
“These results suggest that the portion of the COMMDs assembled into the CCC complexes is particularly disturbed by removal of another COMMD protein.”
Quote in the paperNot a substantial claim - Interpretationown data
CCC complex-mediated LDLR trafficking is conserved between mice and humans.
“Now, we provide genetic evidence that CCDC22 insufficiency directly cause high plasma LDL cholesterol levels in X-linked intellectual disability patients and establish that CCC complex-mediated LDLR trafficking is conserved between mice and humans.”
Quote in the paperSubstantial claim - Interpretationown data
Specific disruption of the CCC core leads to the hypercholesterolemic phenotype.
“This loss of the CCC core subunits was correlated with elevated plasma LDL cholesterol levels in all our models, 8 indicating that specific disruption of the CCC core leads to the hypercholesterolemic phenotype.8,11”
Quote in the paperSubstantial claim - Interpretationreasoning
The exacerbation of hyperlipidemia by hepatic CCC complex perturbation is likely because of a defect in LDLR- and LRP1-mediated lipoprotein clearance.
“Taken together, hepatic perturbations in the CCC complex exacerbates hyperlipidemia-likely because of a defect in LDLR and LRP1-mediated lipoprotein clearanceand accelerates atherosclerosis in ApoE3*L mice.”
Quote in the paperSubstantial claim
- It may state two separate claims as one. 34
- The quote only partly states this claim. 1
- Probably not a substantial claim. 10
It may state two separate claims as one.
Findingown dataPlasma triglyceride, hepatic cholesterol, and triglyceride concentrations were unaltered by hepatic Commd6 ablation.
“Plasma triglyceride, hepatic cholesterol, and triglyceride concentrations were unaltered by hepatic Commd6 ablation”
Quote in the paperNot a substantial claimIt may state two separate claims as one.
Findingown dataDepletion of Commd6 in mouse hepatocytes blunted COMMD1 protein levels, accompanied by reduced protein levels of the CCC core components CCDC22 and CCDC93.
“depletion of Commd6 in mouse hepatocytes blunted COMMD1 protein levels, accompanied by reduced protein levels of the CCC core components CCDC22 and CCDC93”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Findingown dataIn WT livers, COMMD1 and COMMD3 had a similar distribution and partially cosedimented with vesicles containing the CCC and WASH complexes; a percentage of COMMD1 and COMMD3 were present in the same fractions as LDLR.
“In WT livers, COMMD1 and COMMD3 had a similar distribution and partially cosedimented with vesicles containing the CCC (CCDC22 and CCDC93) and WASH (WASH1 and FAM21) complexes.Furthermore, a percentage of COMMD1 and COMMD3 were present in the same fractions as LDLR”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Findingown dataAblation of COMMD6 impaired the total expression and the expression of LDLR at the plasma membrane.
“Ablation of COMMD6 impaired the total expression and the expression of LDLR at the plasma membrane”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Findingown dataCCDC22 inactivation did not alter body weight, liver weight, or cause overt liver pathology.
“CCDC22 inactivation did not alter the body weight, liver weight, or cause overt liver pathology”
Quote in the paperNot a substantial claimIt may state two separate claims as one.
Findingown dataSilencing of COMMD6 significantly decreased COMMD1 protein levels without affecting COMMD1 mRNA.
“silencing of COMMD6 significantly decreased COMMD1 protein levels (Figure 2A) without affecting COMMD1 mRNA”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Findingown dataHepatic expression of the 3 gRNAs reduced CCDC22 expression by ≈70% and diminished the levels of CCDC93, C16orf62, and COMMD1.
“Hepatic expression of the 3 gRNAs reduced CCDC22 expression by ≈70% and diminished the levels of CCDC93, C16orf62, and COMMD1”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Findingown dataInactivation of the CCC complex notably increases very-low-density lipoprotein cholesterol and LDL cholesterol levels, supported by increased plasma ApoB100 levels.
“Very-lowdensity lipoprotein cholesterol and LDL cholesterol levels were notably increased by inactivation of the CCC complex (Figure 7B), supported by the increased plasma ApoB100 levels.”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Findingown dataUsing liver-specific knockout mice for Commd1, Commd6, Commd9, and Ccdc22, the integrity of the CCC complex and the protein stability of all members of the COMMD family are dependent on each other.
“Using liver-specific knockout mice for Commd1, Commd6, Commd9, and Ccdc22, we show that the integrity of the CCC complex and the protein stability of all members of the COMMD family are dependent on each other”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Findingown dataPlasma ApoA1 levels were increased (P<0.01) in Commd6ΔHep mice after feeding chow diet but not on HFC diet feeding.
“Plasma ApoA1 levels were also increased (P<0.01) in Commd6Δ Hep mice but only after feeding chow diet and not on HFC diet feeding”
Quote in the paperNot a substantial claimIt may state two separate claims as one.
Findingown dataNot only the surface levels of LDLR are affected by CCC inactivation but also the surface levels of LRP1.
“we found that not only the surface levels of LDLR are affected by CCC inactivation but also the surface levels of LRP1”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Findingown dataAtherosclerotic lesions in the aortic root were small and foam-cell rich.
“Atherosclerotic lesions in the aortic root were small and foam-cell rich (Figure 7C and 7D).”
Quote in the paperNot a substantial claimIt may state two separate claims as one.
Findingown dataDeletion of hepatic Commd6 markedly decreased all detectable COMMD proteins, but not all to the same degree; COMMD3 levels were only moderately decreased compared with other COMMD proteins.
“Deletion of hepatic Commd6 markedly decreased all detectable COMMD proteins (Figure 3A), however, not all to the same degree (Figure 3A), as COMMD3 levels were only moderately decreased compared with other COMMD proteins”
Quote in the paperNot a substantial claimIt may state two separate claims as one.
Findingown dataThe protein and mRNA levels of COMMD6 were both markedly reduced in HEK293T and RAW264.7 cells expressing short hairpin RNA targeting COMMD6.
“The protein and mRNA levels of COMMD6 were both markedly reduced in HEK293T and RAW264.7 cells expressing short hairpin RNA targeting COMMD6”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Findingown dataIncreased plasma cholesterol levels after CCDC22 inactivation were because of increased plasma LDL cholesterol, supported by increased plasma ApoB100 levels.
“Lipoprotein fractionation by fast-performance liquid chromatography revealed that increased plasma cholesterol levels were because of increased plasma LDL cholesterol (Figure 5D), supported by the increased plasma ApoB100 levels”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Findingown dataHepatic COMMD1 inactivation blunted the expression of CCDC22 and CCDC93 and markedly abolished COMMD3 associated with the CCC and WASH complexes and LDLR, without affecting COMMD3 present in other fractions.
“Hepatic COMMD1 inactivation not only blunted the expression of CCDC22 and CCDC93 (Figure 4A) but also markedly abolished COMMD3 associated with the CCC and WASH complexes and LDLR, without affecting COMMD3 present in other fractions”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Findingown dataHepatic COMMD6 deficiency resulted in a ≈37% increase (P<0.01) in plasma TC levels on a chow diet and a ≈40% increase (P<0.001) in plasma TC levels on a high-fat high-cholesterol diet compared with WT animals.
“hepatic COMMD6 deficiency resulted in a ≈37% increase (P<0.01) in plasma TC levels on a chow diet and a ≈40% increase (P<0.001) in plasma TC levels on a high-fat high-cholesterol (HFC) diet compared with WT animals”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Findingown dataCRISPR/Cas9-mediated somatic gene targeting achieved extensive reduction in hepatocyte CCDC22 levels and provided evidence for a direct role for the core of the CCC complex in regulating plasma cholesterol levels in mice.
“Indeed, using CRISPR/Cas9-mediated somatic gene targeting, we achieved extensive reduction in hepatocyte CCDC22 levels and provided evidence for a direct role for the core of the CCC complex in the regulating of plasma cholesterol levels in mice.”
Quote in the paperSubstantial claimThe quote only partly states this claim.
Findingown dataThe stability of the core of the CCC complex depends on numerous COMMDs, as CCDC22, CCDC93, and C16orf62 levels are massively reduced on hepatic deletion of Commd1, Commd6, or Commd9.
“we identified for the first time that the stability of the core of the CCC complex depends on numerous COMMDs, as CCDC22, CCDC93, and C16orf62 levels were massively reduced on hepatic deletion of Commd1,”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Findingown dataDestabilization of the CCC complex exacerbates dyslipidemia and atherosclerosis.
“Destabilization of the CCC (COMMD-CCDC22-CCDC93) complex exacerbates dyslipidemia and atherosclerosis.”
Quote in the paperSubstantial claimProbably not a substantial claim. It may state two separate claims as one.
Interpretationnone givenThis study provides novel insights into the molecular organization of the endosomal sorting machinery in the coordination of intracellular trafficking of members of the LDLR family, such as LDLR and LRP1, and implies that all 10 COMMD proteins and the CCC core components may be potential targets modulating plasma lipid levels in humans.
“This study provides novel insights into the molecular organization of the endosomal sorting machinery in the coordination of intracellular trafficking of members of the LDLR family, such as LDLR and LRP1 (LDLR-related protein 1) and imply that all 10 COMMD proteins and the CCC core components may be potential targets modulating plasma lipid levels in humans.”
Quote in the paperSubstantial claim- Rests on an assumption: The mechanism preventing the lysosomal fate and directing LDLR back to the cell surface is not fully elucidated.
- Rests on an assumption: The role of COMMD proteins in the regulation of plasma cholesterol levels and atherogenesis has yet to be determined.
- Rests on an assumption: The mechanisms by which intracellular LDLR trafficking is orchestrated remain unclear.
It may state two separate claims as one.
PremisecitationApoE3*Leiden transgenic mice are hyperlipidemic, develop atherosclerosis, and express LDLR in their livers.
“We used ApoE3*Leiden (ApoE3*L) transgenic mice as a model for atherosclerosis 30 because these mice are hyperlipidemic, develop atherosclerosis, and express LDLR in their livers, 31”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [30]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [31]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationCOMMD1 facilitates endosomal trafficking of other receptors, such as ATP7A and ATP7B, to maintain copper homeostasis.
“In addition to LDLR, COMMD1 also facilitates the endosomal trafficking of other receptors, such as the copper transporting protein ATP7A (ATPase copper transporting α) and ATP7B (ATPase copper transporting β), to maintain copper homeostasis.[9][10][11]”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [9]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [10]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [11]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
PremisecitationCommd1, Commd6, Commd9, or Commd10 knockout mice are embryonically lethal and die at different stages of embryogenesis, suggesting nonredundant functions of COMMD proteins during development.
“Commd1, Commd6, Commd9, or Commd10 knockout mice are embryonically lethal [17][18][19][20] and die at different stages of embryogenesis, suggesting nonredundant functions of COMMD proteins during development.”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [17]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [18]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [19]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [20]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
It may state two separate claims as one.
InterpretationreasoningReduced surface levels of LDLR and LRP1 eventually resulted in increased plasma ApoB-containing particles and accelerated atherosclerosis in mice.
“These reduced surface levels of LDLR and LRP1 eventually resulted in increased plasma ApoB-containing particles and accelerated atherosclerosis in mice.”
Quote in the paperSubstantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
PremisecitationCOMMD1 belongs to the COMMD family, which consists of 10 members, each characterized by a carboxyl-terminal COMM domain that mediates physical interaction with other COMMD proteins.
“COMMD1 belongs to the COMMD family, which consists of 10 members, each characterized by a carboxyl-terminal COMM (copper metabolism MURR1) domain, which mediates physical interaction with other COMMD proteins.15”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [15]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
It may state two separate claims as one.
PremisecitationLoss of hepatic COMMD1 impairs endocytic LDLR recycling, which subsequently results in increased plasma LDL cholesterol in dogs and mice.
“Loss of hepatic COMMD1 impairs the endocytic LDLR recycling, which subsequently results in increased levels of plasma LDL cholesterol in dogs and mice.8”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [8]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
PremisecitationCOMMD proteins are ubiquitously expressed and conserved throughout evolution from lower organisms to higher vertebrates.
“COMMD proteins are ubiquitously expressed and are conserved throughout evolution from lower organisms to higher vertebrates.15,16”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [15]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [16]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
It may state two separate claims as one.
Interpretationown dataBoth COMMD6 and COMMD1 are localized in a WASH and retromer-enriched subcompartment of the endosome.
“These observations indicate that both COMMD6 and COMMD1 are localized in a WASH and retromer-enriched subcompartment of the endosome”
Quote in the paperSubstantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationSeveral proteins, such as PCSK9 and IDOL, avert the reuse of LDLR by directing LDLR to lysosomes.
“several proteins, such as PCSK9 (proprotein convertase subtilisin/kexin type 9) and IDOL (inducible degrader of the LDLR), [5][6][7] have been identified that avert the reuse of LDLR through directing LDLR to the lysosomes”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [5]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [6]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [7]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
It may state two separate claims as one.
PremisecitationHeterozygous loss of Commd1 or Commd6 does not alter plasma cholesterol levels.
“Heterozygous loss of Commd1 or Commd6 does not alter plasma cholesterol levels (B.van de Sluis, unpublished data, 2017), 8,10”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [8]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [10]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
It may state two separate claims as one.
Interpretationown dataThe integrity of CCC core complex (CCDC22, CCDC93, and C16orf62) and the protein expression of all COMMDs depend on the expression of COMMD1 and COMMD6.
“these results suggest that the integrity of CCC core complex (CCDC22, CCDC93, and C16orf62) and the protein expression of all COMMDs depend on the expression of COMMD1 and COMMD6.”
Quote in the paperSubstantial claimProbably not a substantial claim.
PremisecitationThe 10 COMMD proteins exist in large macromolecular complexes containing the CCC core components CCDC22, CCDC93, and C16orf62.
“Although several studies have shown that the 10 COMMD proteins exist in large macromolecular complexes containing the CCC core components CCDC22, CCDC93, and C16orf62, 9,18,21,22”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [9]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [18]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [21]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [22]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
PremisecitationWASH activates the Arp2/3 complex to deposit branched actin filaments on endosomes, which is essential for the architecture of the endosomal and lysosomal network and endosomal receptor trafficking.
“WASH activates the Arp2/3 (actin-related protein 2/3) complex to deposit branched actin filaments on endosomes, which is essential for the architecture of the endosomal and lysosomal network and endosomal receptor trafficking.[12][13][14]”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [12]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [13]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [14]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
It may state two separate claims as one.
Interpretationown dataThe protein expression of COMMDs relies on each other through forming multiprotein complexes, and the degree of dependency differs between COMMD proteins.
“Taken together, these results indicate that the protein expression of COMMDs relies on each other through forming multiprotein complexes, and the degree of dependency differs between COMMD proteins.”
Quote in the paperSubstantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it.
InterpretationcitationThe CCC complex may have a role in SR-B1-mediated high-density lipoprotein cholesteryl esters uptake.
“Because different studies have shown that SR-B1 can be endocytosed, 40 this may indicate that the CCC complex has also a role in SR-B1-mediated high-density lipoprotein cholesteryl esters uptake, but further studies are warranted.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [40]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
It may state two separate claims as one.
InterpretationreasoningThe fraction of a COMMD protein not affected by loss of another COMMD protein is likely present in other cellular compartments, where they likely mediate other biological activities.
“The fraction of a COMMD protein that is not affected by the loss of another COMMD protein is likely present in other cellular compartments, where they likely mediate other biological activities of these factors, similarly to what has been reported for COMMD1, which can also regulate NF-κB (nuclear factor kappa B) and HIF-1 (hypoxia inducible factor 1) signaling.17,19,32”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [17]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [19]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [32]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
It may state two separate claims as one.
Interpretationown dataThe COMMD proteins maintain the integrity and function of the hepatocyte CCC complex during endosomal LDLR and LRP1 trafficking.
“Collectively, our study has uncovered a previously unknown role for the evolutionarily conserved COMMD proteins in maintaining the integrity and function of the hepatocyte CCC complex during endosomal LDLR and LRP1 trafficking.”
Quote in the paperSubstantial claimIt may state two separate claims as one.
InterpretationreasoningHepatic CCC deficiency leads to increased plasma LDL cholesterol levels and accelerated atherosclerosis.
“Although the total protein levels of hepatic LDLR and LRP1 in WT and ApoE3*L mice are not affected on CCC inactivation, this study and our previous work 8 showed that hepatic CCC deficiency reduces surface levels of LDLR and LRP1-likely because of impaired endosomal receptor trafficking 8 -leading to increased plasma LDL cholesterol levels and accelerated atherosclerosis (Online Figure IX).”
Quote in the paperSubstantial claimProbably not a substantial claim.
PremisecitationThe CCC complex is a novel factor of endosomal LDLR trafficking.
“Recently, the CCC complexa multiprotein complex associated with vital elements of the endocytic sorting machinery 9 -was identified as a novel factor of endosomal LDLR trafficking (Online Figure IX).8”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [8]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
The paper relies on this without support.
The mechanism preventing the lysosomal fate and directing LDLR back to the cell surface is not fully elucidated.
“but the mechanism preventing the lysosomal fate and directing LDLR back to the cell surface is still not fully elucidated.”
The paper relies on this without support.
The role of COMMD proteins in the regulation of plasma cholesterol levels and atherogenesis has yet to be determined.
“their role in the regulation of plasma cholesterol levels and atherogenesis has yet to be determined.”
The paper relies on this without support.
The mechanisms by which intracellular LDLR trafficking is orchestrated remain unclear.
“but the mechanisms by which intracellular LDLR trafficking is orchestrated remain unclear.”
The paper relies on this without support.
Evaluating the contribution of the CCC complex to dyslipidemia and atherogenesis requires hepatic LDLR expression.
“which we thought to be essential in evaluating the contribution of the CCC complex to dyslipidemia and atherogenesis.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The CCDC22-CCDC93 heterodimer is destabilized whenever any given COMMD protein is knocked out in cells or tissues.
“This could explain why the CCDC22-CCDC93 heterodimer is destabilized whenever any given COMMD protein is knocked out in cells or in tissues14,25,46.”
From Structural organization of the retriever–CCC endosomal recycling complex (2024) · cites this paper as [46]
The ‘Stability of COMMD Proteins Associated With the CCC Complex’ section reports reduced CCDC22 and CCDC93 in livers deficient in COMMD1, COMMD6, or COMMD9; the COMMD6 section also reports reduced levels after COMMD6 depletion in cells. The Discussion limits its conclusion to ‘any COMMD studied,’ so the paper does not establish that this happens whenever any member of the COMMD family is knocked out. (LLM, conf=0.88)
Experimental — accuracy not yet measuredCCC is required for retromer- and retriever-dependent protein trafficking.
“the CCC protein complex, which consists of CCDC22, CCDC93, and any of the 10 COMMD proteins, is required for retromer- and retriever-dependent protein trafficking27–32”
From Endosomal PI(3)P regulation by the COMMD/CCDC22/CCDC93 (CCC) complex controls membrane protein recycling (2019) · cites this paper as [32]
The Abstract describes CCC as containing COMMD proteins, CCDC22, and CCDC93, and says its recruitment to endosomes depends on the retromer subunit VPS35. The Discussion says retriever recruitment relies on CCC and WASH and reports that inactivating CCC affects LDLR and LRP1 trafficking. These passages support a role in both pathways, but do not establish that CCC is required for retromer- and retriever-dependent protein trafficking generally; the paper also treats the precise organization of the retriever–CCC pathway as unresolved. Page numbers are unavailable in our copy. (LLM, conf=0.84)
Experimental — accuracy not yet measuredCCC deficiency in human and mouse cells causes defective recycling of SNX17-retriever cargoes such as β1 integrin, LDLR, and LRP1.
“CCC deficiency in human and mouse cells causes defective recycling of SNX17-retriever cargoes such as β1 integrin, LDLR, and LRP120,31,32”
From Endosomal PI(3)P regulation by the COMMD/CCDC22/CCDC93 (CCC) complex controls membrane protein recycling (2019) · cites this paper as [32]
The Discussion (page unavailable) reports that CCC inactivation affects LDLR and LRP1 function and reduces their surface levels in mouse liver, likely through impaired endosomal trafficking. It describes their recycling through the SNX17–CCC–WASH pathway as a speculation, not an established retriever-cargo result. The passages do not establish defective β1-integrin recycling or the claimed recycling defect in human cells. (LLM, conf=0.85)
Experimental — accuracy not yet measuredThe CCC protein complex consists of CCDC22, CCDC93, and any of the 10 COMMD proteins.
“the CCC protein complex, which consists of CCDC22, CCDC93, and any of the 10 COMMD proteins”
From Endosomal PI(3)P regulation by the COMMD/CCDC22/CCDC93 (CCC) complex controls membrane protein recycling (2019) · cites this paper as [32]
The section on COMMD protein stability identifies CCDC22 and CCDC93 as CCC core components and describes their association with COMMD proteins. But it repeatedly identifies C16orf62 as a third CCC core component, which the claimed description of what the complex consists of omits. Our copy also describes all 10 COMMD proteins as assembled into CCC complexes, rather than specifying that a complex contains any one of them. Page numbers are not provided for these passages. (LLM, conf=0.90)
Experimental — accuracy not yet measuredThe fact that the endosomal recycling process is primarily regulated at the post-translational (protein) level supports the hypothesis that the CCDC93 variant (rs17512204) encodes a protein with improved function.
“This can be explained by the fact that this process is primarily regulated at the post-translational (protein) level, 12,13,40 which, in turn, supports our hypothesis that the CCDC93 variant (rs17512204) encodes a protein with improved function.”
From A common variant in CCDC93 protects against myocardial infarction and cardiovascular mortality by regulating endosomal trafficking of low-density lipoprotein receptor (2020) · cites this paper as [12]
In “COMMD6 Is Indispensable for COMMD1, CCDC22, and CCDC93 Protein Expression” (page unavailable), the paper reports reduced CCC-component protein levels without aberrant gene expression and links protein stability to endosomal receptor recycling. This supports protein-level regulation of the CCC complex, but not the broader assertion that endosomal recycling is primarily regulated post-translationally. The CCDC93-variant hypothesis is the citing authors’ own inference, not a finding attributed to this source. (LLM, conf=0.83)
Experimental — accuracy not yet measured
A complete loss of components of the endosomal recycling machinery is lethal in mice.
“This combined with the notion that a complete loss of components of the endosomal recycling machinery is lethal in mice 12,13,37 indicated that impairment of this pathway is very harmful.”
From A common variant in CCDC93 protects against myocardial infarction and cardiovascular mortality by regulating endosomal trafficking of low-density lipoprotein receptor (2020) · cites this paper as [12]
The References section (page unavailable) lists a study whose title reports early embryonic lethality in Commd1-null mice, supporting the claim for one component. This paper’s own mouse experiments use liver-specific deletions and do not establish that complete loss of components of the endosomal recycling machinery generally is lethal. (LLM, conf=0.77)
Experimental — accuracy not yet measuredMost transmembrane proteins sorted by Commander contain ΦxNxx[YF] sequence motifs that are recruited to Commander via the sorting nexin 17 (SNX17) cargo adaptor.
“Most transmembrane proteins sorted by Commander, including α5β1 integrin, the amyloid precursor protein (APP), and lipoprotein receptors contain ΦxNxx[YF] sequence motifs (where Φ is a hydrophobic amino acid) that are recruited to Commander via the sorting nexin 17 (SNX17) cargo adaptor.6,20,23,24,25,26,27,28,29”
From Structure of the endosomal Commander complex linked to Ritscher-Schinzel syndrome (2023) · cites this paper as [28]
The Discussion (page not provided) says LDLR and LRP1 contain an NPxY motif that binds SNX17 and COMMD1, and proposes that SNX17 and the CCC complex participate in their recycling. It does not establish that most Commander-sorted transmembrane proteins have the specified ΦxNxx[YF] motif, or address α5β1 integrin and APP as examples; the proposed trafficking mechanism is also presented as speculation. (LLM, conf=0.87)
Experimental — accuracy not yet measuredThe structure provides an atomic level description of its organization that explains previous results including the co-dependence of each of the COMMD, CCDC, and VPS35L proteins for complex stability.
“the structure provides an atomic level description of its organization that explains previous results including the co-dependence of each of the COMMD, CCDC, and VPS35L proteins for complex stability.13,28”
From Structure of the endosomal Commander complex linked to Ritscher-Schinzel syndrome (2023) · cites this paper as [28]
In “Stability of COMMD Proteins Associated With the CCC Complex Depends on Other COMMD Proteins” (page unavailable), the paper reports that loss of COMMD proteins reduces other COMMD proteins and the CCC components CCDC22, CCDC93, and C16orf62. It does not establish the claimed co-dependence of each COMMD, CCDC, and VPS35L protein: the reported experiments primarily test COMMD loss, and the copy does not identify VPS35L by that name. The atomic-level structural description is the citing authors’ own finding, not a finding attributed to this source. (LLM, conf=0.84)
Experimental — accuracy not yet measuredPCSK9 does not have an effect on hepatic LRP1 degradation in WT mice.
“although PCSK9 does not have an effect on hepatic LRP1 degradation in WT mice (17,37,38)”
From The hepatic WASH complex is required for efficient plasma LDL and HDL cholesterol clearance (2019) · cites this paper as [17]
In the hepatic CCC-complex ablation results (page unavailable), PCSK9-D377Y reduced hepatic LDLR protein expression but not LRP1 protein expression in WT mice. This supports no observed effect on LRP1 abundance under that condition, but the paper does not directly measure LRP1 degradation or establish the claim for PCSK9 generally. (LLM, conf=0.84)
Experimental — accuracy not yet measuredLoss of the CCC complex leads to increased expression of several WASH subunits, including WASHC1.
“we have shown that loss of the CCC complex leads to increased expression of several WASH subunits, including WASHC1 (17).”
From The hepatic WASH complex is required for efficient plasma LDL and HDL cholesterol clearance (2019) · cites this paper as [17]
In “Stability of COMMD Proteins Associated With the CCC Complex Depends on Other COMMD Proteins” (page unavailable), the paper reports that loss of COMMD1 or COMMD6 reduced CCC core subunits and increased expression of the WASH component WASH1, also called WASHC1. It does not report increased expression of several WASH subunits; its mention of FAM21 concerns colocalization, not increased expression. (LLM, conf=0.87)
Experimental — accuracy not yet measuredMutations in WASHC5, CCDC22 and VPS35L all result in hypercholesterolemia in humans, thought to be due to abnormal LDL clearance secondary to defects in LDL receptor recycling.
“It is worth noting that mutations in WASHC5, CCDC22 and VPS35L all result in hypercholesterolemia in humans thought to be due to abnormal LDL clearance secondary to defects in LDL receptor recycling, a phenotype also seen in mouse models of liver deficiency of Ccdc22, Vps35l and Commd1 [5, 7, 30–32].”
From CCDC22 mutations that impair COMMD binding cause attenuated 3C/Ritscher-Schinzel syndrome (2025) · cites this paper as [31]
The Discussion (page unavailable) reports that CCDC22 mutations are associated with hypercholesterolemia in humans and links CCC-complex deficiency to impaired LDLR trafficking and elevated LDL cholesterol in mice. The paper also reports a mouse model with hepatic Ccdc22 inactivation. Our copy does not establish the claimed human hypercholesterolemia for WASHC5 or VPS35L mutations, or the cited liver-deficient Vps35l mouse phenotype. (LLM, conf=0.89)
Experimental — accuracy not yet measuredThe CCC complex has been recognized for its role in regulating endosomal recycling of various cargos.
“The CCC complex is a molecular assembly that has been recognized for its role in regulating endosomal recycling of various cargos20,27,30–32,34”
From Endosomal PI(3)P regulation by the COMMD/CCDC22/CCDC93 (CCC) complex controls membrane protein recycling (2019) · cites this paper as [32]
Loss of proteins of the CCC complex studied thus far causes hypercholesterolaemia in mammals including man.
“Loss of proteins of the CCC complex studied thus far causes hypercholesterolaemia in mammals including man.”
CCDC93 participates in an evolutionary conserved multiprotein complex, the CCC complex (COMMD/CCDC22/CCDC93), that orchestrates the endosomal recycling of the LDL-receptor (LDLR).
“This because we have recently shown that CCDC93 participates in an evolutionary conserved multiprotein complex, annotated as the CCC complex (COMMD/CCDC22/CCDC93; see Supple- mentary material online for additional information), that orchestrates the endosomal recycling of the LDL-receptor (LDLR).12,13”
Experimental studies in mice have shown that a loss of proteins of the endosomal sorting machinery causes hypercholesterolaemia and increased atherosclerosis.
“These experimental studies in mice have shown that a loss of proteins of the endosomal sorting machinery causes hypercholesterolaemia and increased atherosclerosis.12,13”
A role for PCSK9 in hepatic LRP1 degradation in WT mice or in hepatic COMMD1-deficient mice could not be confirmed.
“However, we and others could not confirm a role for PCSK9 in hepatic LRP1 degradation in WT mice, nor in hepatic COMMD1-deficient mice (17,37,38).”
From The hepatic WASH complex is required for efficient plasma LDL and HDL cholesterol clearance (2019) · cites this paper as [17]
Hepatic loss of proteins in the CCC has been shown to result in increased plasma lipid levels due to reductions in LDLR.
“Hepatic loss of proteins in the CCC has been shown to result in increased plasma lipid levels due to reductions in LDLR99.”
From Pathways and Molecular Mechanisms Governing LDL Receptor Regulation (2025) · cites this paper as [99]
The CCC and WASH complexes act together to facilitate endosomal trafficking of LDLR.
“Previous reports found the CCC and WASH complexes act together to facilitate endosomal trafficking of LDLR.17 30 31”
From Clinical diversity and molecular mechanism of VPS35L-associated Ritscher-Schinzel syndrome (2023) · cites this paper as [30]
Both CCDC93 and the CCC complex mediate endosomal sorting of the low-density lipoprotein receptor (LDLR).
“Both CCDC93 and the CCC complex mediate endosomal sorting of the low-density lipoprotein receptor (LDLR) [43,48,49].”
From Genetic variation in CCDC93 is associated with elevated central systolic blood pressure, impaired arterial relaxation, and mitochondrial dysfunction (2024) · cites this paper as [48]
Citations
Cites
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
The metabolic and molecular bases of inherited disease
Chen, Y.-T. (2001) · Medical Entomology and Zoology · Cited by 6,928
A Receptor-Mediated Pathway for Cholesterol Homeostasis
Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703
LXR Regulates Cholesterol Uptake Through Idol-Dependent Ubiquitination of the LDL Receptor
Zelcer, N., Hong, C., Boyadjian, R., & Tontonoz, P. (2009) · Science · doi:10.1126/science.1168974 · Cited by 848
Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and inlivers of parabiotic mice
Lagace, T. A., Curtis, D. E., Garuti, R., McNutt, M. C., Park, S. W., Prather, H. B., Anderson, N. N., Ho, Y. K., Hammer, R. E., & Horton, J. D. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29383 · Cited by 681
NARC-1/PCSK9 and Its Natural Mutants
Benjannet, S., Rhainds, D., Essalmani, R., Mayne, J., Wickham, L., Jin, W., Asselin, M.-C., Hamelin, J., Varret, M., Allard, D., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409699200 · Cited by 587
Panorama of ancient metazoan macromolecular complexes
Wan, C., Borgeson, B., Phanse, S., Tu, F., Drew, K., Clark, G. W., Xiong, X., Kagan, O., Kwan, J., Bezginov, A., et al. (2015) · Nature · doi:10.1038/nature14877 · Cited by 522
A FAM21-Containing WASH Complex Regulates Retromer-Dependent Sorting
Gomez, T. S., & Billadeau, D. D. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.09.009 · Cited by 521
Self-citationRohlmann, A., Gotthardt, M., Hammer, R. E., & Herz, J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1240 · Cited by 455 · cited 3×
“As LDLR can compensate for the loss of LRP1, studying LRP1 functioning in the clearance of plasma ApoE and ApoB-containing particles in mice is only possible in a hepatic LDLR-deficient background (27).”
BackgroundInfluentialPratt, J. M., Simpson, D. M., Doherty, M. K., Rivers, J., Gaskell, S. J., & Beynon, R. J. (2006) · Nature Protocols · doi:10.1038/nprot.2006.129 · Cited by 375
Retriever is a multiprotein complex for retromer-independent endosomal cargo recycling
McNally, K. E., Faulkner, R., Steinberg, F., Gallon, M., Ghai, R., Pim, D., Langton, P., Pearson, N., Danson, C. M., Nägele, H., et al. (2017) · Nature Cell Biology · doi:10.1038/ncb3610 · Cited by 346
Self-citationInduction of Atherosclerosis in Mice and Hamsters Without Germline Genetic Engineering
Bjørklund, M. M., Hollensen, A. K., Hagensen, M. K., Dagnæs‐Hansen, F., Christoffersen, C., Mikkelsen, J. G., & Bentzon, J. F. (2014) · Circulation Research · doi:10.1161/circresaha.114.302937 · Cited by 317
Identification of a new copper metabolism gene by positional cloning in a purebred dog population
van de Sluis, B. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.2.165 · Cited by 312
COMMD Proteins, a Novel Family of Structural and Functional Homologs of MURR1
Burstein, E., Hoberg, J. E., Wilkinson, A. S., Rumble, J. M., Csomos, R. A., Komarck, C. M., Maine, G. N., Wilkinson, J. C., Mayo, M. W., & Duckett, C. S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501928200 · Cited by 258
Self-citationDiet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice.
van Vlijmen, B. J. M., van den Maagdenberg, A. M. J. M., Gijbels, M. J., van der Boom, H., HogenEsch, H., Frants, R. R., Hofker, M. H., & Havekes, L. M. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117117 · Cited by 250
Self-citationPhillips-Krawczak, C. A., Singla, A., Starokadomskyy, P., Deng, Z., Osborne, D. G., Li, H., Dick, C. J., Gomez, T. S., Koenecke, M., Zhang, J.-S., et al. (2015) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-06-1073 · Cited by 246
Self-citationHarbour, M. E., Breusegem, S. Y., & Seaman, M. N. J. (2012) · Biochemical Journal · doi:10.1042/bj20111761 · Cited by 238
Retromer-mediated endosomal protein sorting: all WASHed up!
Seaman, M. N. J., Gautreau, A. M., & Billadeau, D. D. (2013) · Trends in Cell Biology · doi:10.1016/j.tcb.2013.04.010 · Cited by 209
Self-citationCCC- and WASH-mediated endosomal sorting of LDLR is required for normal clearance of circulating LDL
Bartuzi, P., Billadeau, D. D., Favier, R., Rong, S., Dekker, D., Fedoseienko, A., Fieten, H., Wijers, M., Levels, J. H., Huijkman, N., et al. (2016) · Nature Communications · doi:10.1038/ncomms10961 · Cited by 205
Self-citationGomez, T. S., Gorman, J. A., Artal-Martinez de Narvajas, A., Koenig, A. O., & Billadeau, D. D. (2012) · Molecular Biology of the Cell · doi:10.1091/mbc.e12-02-0101 · Cited by 161
Self-citationTuning NF-κB activity: A touch of COMMD proteins
Bartuzi, P., Hofker, M. H., & van de Sluis, B. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.09.014 · Cited by 142
Self-citationLipoprotein receptors – an evolutionarily ancient multifunctional receptor family
Dieckmann, M., Dietrich, M. F., & Herz, J. (2010) · Biological Chemistry · doi:10.1515/bc.2010.129 · Cited by 135
Stockinger, W., Sailler, B., Strasser, V., Recheis, B., Fasching, D., Kahr, L., Schneider, W. J., & Nimpf, J. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf435 · Cited by 130
COMMD1 disrupts HIF-1α/β dimerization and inhibits human tumor cell invasion
van de Sluis, B., Mao, X., Zhai, Y., Groot, A. J., Vermeulen, J. F., van der Wall, E., van Diest, P. J., Hofker, M. H., Wijmenga, C., Klomp, L. W. J., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40583 · Cited by 130
Self-citationCCDC22 deficiency in humans blunts activation of proinflammatory NF-κB signaling
Starokadomskyy, P., Gluck, N., Li, H., Chen, B., Wallis, M., Maine, G. N., Mao, X., Zaidi, I. W., Hein, M. Y., McDonald, F. J., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66466 · Cited by 115
Self-citationCharacterization of COMMD protein–protein interactions in NF-κB signalling
de Bie, P., van de Sluis, B., Burstein, E., Duran, K. J., Berger, R., Duckett, C. S., Wijmenga, C., & Klomp, L. W. J. (2006) · Biochemical Journal · doi:10.1042/bj20051664 · Cited by 114
Self-citationvan de Sluis, B., Wijers, M., & Herz, J. (2017) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000411 · Cited by 111
Self-citationvan de Sluis, B., Muller, P., Duran, K., Chen, A., Groot, A. J., Klomp, L. W., Liu, P. P., & Wijmenga, C. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01932-06 · Cited by 105
Wang, Y., Huang, Y., Hobbs, H. H., & Cohen, J. C. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m028563 · Cited by 104
HDL endocytosis and resecretion
Röhrl, C., & Stangl, H. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.07.014 · Cited by 101
Systems-wide Studies Uncover Commander, a Multiprotein Complex Essential to Human Development
Mallam, A. L., & Marcotte, E. M. (2017) · Cell Systems · doi:10.1016/j.cels.2017.04.006 · Cited by 94
van Vlijmen, B. J. M., Hof, H. B. V. '., Mol, M. J. T. M., van der Boom, H., van der Zee, A., Frants, R. R., Hofker, M. H., & Havekes, L. M. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118532 · Cited by 91
Self-citationBurden, J. J., Sun, X.-M., García, A. B. G., & Soutar, A. K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313689200 · Cited by 82
Endosomal sorting of Notch receptors through COMMD9-dependent pathways modulates Notch signaling
Li, H., Koo, Y., Mao, X., Sifuentes-Dominguez, L., Morris, L. L., Jia, D., Miyata, N., Faulkner, R. A., van Deursen, J. M., Vooijs, M., et al. (2015) · Journal of Cell Biology · doi:10.1083/jcb.201505108 · Cited by 73
Self-citationSemenova, E. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg140 · Cited by 69
Donoso, M., Cancino, J., Lee, J., van Kerkhof, P., Retamal, C., Bu, G., Gonzalez, A., Cáceres, A., & Marzolo, M.-P. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-08-0805 · Cited by 69
Liver-Specific Commd1 Knockout Mice Are Susceptible to Hepatic Copper Accumulation
Vonk, W. I. M., Bartuzi, P., de Bie, P., Kloosterhuis, N., Wichers, C. G. K., Berger, R., Haywood, S., Klomp, L. W. J., Wijmenga, C., & van de Sluis, B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0029183 · Cited by 61
Self-citationThe life cycle of the low-density lipoprotein receptor: insights from cellular and in-vivo studies
Wijers, M., Kuivenhoven, J. A., & van de Sluis, B. (2015) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000157 · Cited by 55
Self-citationFarfán, P., Lee, J., Larios, J., Sotelo, P., Bu, G., & Marzolo, M. (2013) · Traffic · doi:10.1111/tra.12076 · Cited by 51
Generation of analytic plasma lipoprotein profiles using two prepacked superose 6B columns
Gerdes, L. U., Gerdes, C., Klausen, I. C., & Færgeman, O. (1992) · Clinica Chimica Acta · doi:10.1016/0009-8981(92)90348-t · Cited by 44
Flagged first, then by citations
1 of the 41 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Mechanisms and regulation of cholesterol homeostasis
Luo, J., Yang, H., & Song, B.-L. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0190-7 · Cited by 1,980
Regulation of glucose and lipid metabolism in health and disease
Chen, L., Chen, X., Huang, X., Song, B., Wang, Y., & Wang, Y. (2019) · Science China Life Sciences · doi:10.1007/s11427-019-1563-3 · Cited by 310
A genome-wide CRISPR screen identifies host factors that regulate SARS-CoV-2 entry
Zhu, Y., Feng, F., Hu, G., Wang, Y., Yin, Y., Zhu, Y., Xü, W., Cai, X., Sun, Z., Han, W., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21213-4 · Cited by 307
The cell biology of the hepatocyte: A membrane trafficking machine
Schulze, R. J., Schott, M. B., Casey, C. A., Tuma, P. L., & McNiven, M. A. (2019) · The Journal of Cell Biology · doi:10.1083/jcb.201903090 · Cited by 277
Hepatic cholesterol transport and its role in non-alcoholic fatty liver disease and atherosclerosis
Li, H., Yu, X.-H., Ou, X., Ouyang, X.-P., & Tang, C. (2021) · Progress in Lipid Research · doi:10.1016/j.plipres.2021.101109 · Cited by 237
Cholesterol and Alzheimer’s Disease; From Risk Genes to Pathological Effects
Feringa, F. M., & van der Kant, R. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.690372 · Cited by 226
Mammalian copper homeostasis: physiological roles and molecular mechanisms
Lutsenko, S., Roy, S., & Tsvetkov, P. (2024) · Physiological Reviews · doi:10.1152/physrev.00011.2024 · Cited by 211
Towards a molecular understanding of endosomal trafficking by Retromer and Retriever
Chen, K., Healy, M. D., & Collins, B. M. (2019) · Traffic · doi:10.1111/tra.12649 · Cited by 193
Endosomal retrieval of cargo: Retromer is not alone
McNally, K. E., & Cullen, P. J. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.06.005 · Cited by 169
Role of Cholesterol and Lipid Rafts in Cancer Signaling: A Promising Therapeutic Opportunity?
Vona, R., Iessi, E., & Matarrese, P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.622908 · Cited by 169
de Boer, J. F., Verkade, E., Mulder, N. L., de Vries, H. D., Huijkman, N., Koehorst, M., Boer, T. S., Wolters, J. C., Bloks, V. W., van de Sluis, B., et al. (2019) · Journal of Lipid Research · doi:10.1194/jlr.ra119000243 · Cited by 146
Self-citationSingla, A., Fedoseienko, A., Giridharan, S. S. P., Overlee, B. L., Lopez, A., Jia, D., Song, J., Huff-Hardy, K., Weisman, L., Burstein, E., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12221-6 · Cited by 113
Self-citationStructure of the endosomal Commander complex linked to Ritscher-Schinzel syndrome
Healy, M. D., McNally, K. E., Butkovič, R., Chilton, M., Kato, K., Sacharz, J., McConville, C., Moody, E. R. R., Shaw, S., Planelles-Herrero, V. J., et al. (2023) · Cell · doi:10.1016/j.cell.2023.04.003 · Cited by 91
Inhibition of PFKFB3 Hampers the Progression of Atherosclerosis and Promotes Plaque Stability
Poels, K., Schnitzler, J. G., Waissi, F., Levels, J. H. M., Stroes, E. S. G., Daemen, M. J. A. P., Lutgens, E., Pennekamp, A.-M., de Kleijn, D. P. V., Seijkens, T. T. P., et al. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.581641 · Cited by 76
Self-citationLaurent, E. M. N., Sofianatos, Y., Komarova, A. V., Gimeno, J., Samavarchi‐Tehrani, P., Kim, D., Abdouni, H. S., Duhamel, M., Cassonnet, P., Knapp, J. J., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.28.272955 · Cited by 75
Membrane Heterogeneity Controls Cellular Endocytic Trafficking
Redpath, G. M. I., Betzler, V. M., Rossatti, P., & Rossy, J. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00757 · Cited by 66
Celastrol suppresses humoral immune responses and autoimmunity by targeting the COMMD3/8 complex
Shirai, T., Nakai, A., Ando, E., Fujimoto, J., Leach, S., Arimori, T., Higo, D., van Eerden, F. J., Tulyeu, J., Liu, Y., et al. (2023) · Science Immunology · doi:10.1126/sciimmunol.adc9324 · Cited by 59
Bosmans, L. A., van Tiel, C. M., Aarts, S. A. B. M., Willemsen, L., Baardman, J., van Os, B. W., den Toom, M., Beckers, L., Ahern, D., Levels, J. H. M., et al. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac084 · Cited by 58
Self-citationEndosomal trafficking in metabolic homeostasis and diseases
Gilleron, J., & Zeigerer, A. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00737-9 · Cited by 57
Structural organization of the retriever–CCC endosomal recycling complex
Boesch, D. J., Singla, A., Han, Y., Kramer, D. A., Liu, Q., Suzuki, K., Juneja, P., Zhao, X., Long, X., Medlyn, M. J., et al. (2024) · Nature Structural & Molecular Biology · doi:10.1038/s41594-023-01184-4 · Cited by 52
Self-citationLoregger, A., Raaben, M., Nieuwenhuis, J., Tan, J. M. E., Jae, L. T., van den Hengel, L. G., Hendrix, S., van den Berg, M., Scheij, S., Song, J.-Y., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14811-1 · Cited by 51
PCSK9 Promotes LDLR Degradation by Preventing SNX17-Mediated LDLR Recycling
Guan, Y., Liu, X., Yang, Z., Zhu, X., Liu, M., Du, M., Pan, X., & Wang, Y. (2025) · Circulation · doi:10.1161/circulationaha.124.072336 · Cited by 50
Yang, M. Y., Huang, W., Sun, Y., Liang, H., Chen, M., Wu, X., Wang, X., Zhang, L., Cheng, X., Fan, Y., et al. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0571-x · Cited by 50
Courtland, J. L., Bradshaw, T. W., Waitt, G., Soderblom, E. J., Ho, T., Rajab, A., Vancini, R., Kim, I. H., & Soderling, S. H. (2021) · eLife · doi:10.7554/elife.61590 · Cited by 49
Structure and interactions of the endogenous human Commander complex
Laulumaa, S., Kumpula, E.-P., Huiskonen, J. T., & Varjosalo, M. (2024) · Nature Structural & Molecular Biology · doi:10.1038/s41594-024-01246-1 · Cited by 46
The Amino Acid Homoarginine Inhibits Atherogenesis by Modulating T-Cell Function
Nitz, K., Lacy, M., Bianchini, M., Wichapong, K., Avcilar-Kücükgöze, I., Bonfiglio, C. A., Migheli, R., Wu, Y., Burger, C., Li, Y., et al. (2022) · Circulation Research · doi:10.1161/circresaha.122.321094 · Cited by 46
Hepatic Rab24 controls blood glucose homeostasis via improving mitochondrial plasticity
Seitz, S., Kwon, Y., Hartleben, G., Jülg, J., Sekar, R., Krahmer, N., Najafi, B., Loft, A., Gancheva, S., Stemmer, K., et al. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0124-x · Cited by 46
Ponsuksili, S., Trakooljul, N., Sajjanar, B., Hadlich, F., Muráni, E., & Wimmers, K. (2019) · BMC Genomics · doi:10.1186/s12864-019-5880-1 · Cited by 45
The hepatic WASH complex is required for efficient plasma LDL and HDL cholesterol clearance
Wijers, M., Zanoni, P., Liv, N., Vos, D. Y., Jäckstein, M. Y., Smit, M., Wilbrink, S., Wolters, J. C., van der Veen, Y. T., Huijkman, N., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.126462 · Cited by 44
Self-citationTaking One Step Back in Familial Hypercholesterolemia
Loaiza, N., Hartgers, M. L., Reeskamp, L. F., Balder, J.-W., Rimbert, A., Bazioti, V., Wolters, J. C., Winkelmeijer, M., Jansen, H., Dallinga‐Thie, G. M., et al. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.119.313470 · Cited by 44
Self-citationMetabolic regulation through the endosomal system
Gilleron, J., Gerdes, J. M., & Zeigerer, A. (2019) · Traffic · doi:10.1111/tra.12670 · Cited by 42
Regulation of murine copper homeostasis by members of the COMMD protein family
Singla, A., Chen, Q., Suzuki, K., Song, J., Fedoseienko, A., Wijers, M., Lopez, A. M., Billadeau, D. D., van de Sluis, B., & Burstein, E. (2020) · Disease Models & Mechanisms · doi:10.1242/dmm.045963 · Cited by 40
Self-citationRAB11-Mediated Trafficking and Human Cancers: An Updated Review
Ferro, E., Bosia, C., & Campa, C. C. (2021) · Biology · doi:10.3390/biology10010026 · Cited by 40
Weiskirchen, R., & Penning, L. C. (2021) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2021.126712 · Cited by 40
Neurotrophins as Key Regulators of Cell Metabolism: Implications for Cholesterol Homeostasis
Colardo, M., Martella, N., Pensabene, D., Siteni, S., Bartolomeo, S. D., Pallottini, V., & Segatto, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115692 · Cited by 39
Vos, D. Y., & van de Sluis, B. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101146 · Cited by 35
Hepatic SREBP signaling requires SPRING to govern systemic lipid metabolism in mice and humans
Hendrix, S., Kingma, J., Ottenhoff, R., Valiloo, M., Svecla, M., Zijlstra, L. F., Sachdev, V., Kovac, K., Levels, J. H. M., Jongejan, A., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40943-1 · Cited by 34
Self-citationNovel aspects of PCSK9 and lipoprotein receptors in renal disease-related dyslipidemia
Shrestha, P., van de Sluis, B., Dullaart, R. P. F., & van den Born, J. (2018) · Cellular Signalling · doi:10.1016/j.cellsig.2018.12.001 · Cited by 34
Pathways and Molecular Mechanisms Governing LDL Receptor Regulation
Schmidt, H. M., Jarrett, K. E., de Aguiar Vallim, T. Q., & Tarling, E. J. (2025) · Circulation Research · doi:10.1161/circresaha.124.323578 · Cited by 33
Ezh2 Shapes T Cell Plasticity to Drive Atherosclerosis
Bonfiglio, C. A., Lacy, M., Triantafyllidou, V., Farina, F. M., Janjic, A., Nitz, K., Wu, Y., Bazioti, V., Avcilar-Kücükgöze, I., Marques, Y. F. S., et al. (2025) · Circulation · doi:10.1161/circulationaha.124.072384 · Cited by 32
Larsen, L. E., van den Boogert, M. A. W., Ríos‐Ocampo, W. A., Jansen, J. C., Conlon, D., Chong, P. L. E., Levels, J. H. M., Eilers, R. E., Sachdev, V., Zelcer, N., et al. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.09.013 · Cited by 30
Self-citationStewart, D. J., Short, K. K., Maniaci, B. N., & Burkhead, J. L. (2019) · Journal of Cell Science · doi:10.1242/jcs.231753 · Cited by 30
Fischer, A. W., Albers, K., Krott, L. M., Hoffzimmer, B., Heine, M., Schmale, H., Scheja, L., Gordts, P. L. S. M., & Heeren, J. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.07.010 · Cited by 29
Song, J., Liu, Y., Wan, J., Zhao, G., Wang, J., Dai, Z., Hu, S., Yang, L., Liu, Z., Fu, Y. F., et al. (2021) · Hepatology · doi:10.1002/hep.32075 · Cited by 28
Mechanism and regulation of cargo entry into the Commander endosomal recycling pathway
Butkovič, R., Walker, A. P., Healy, M. D., McNally, K. E., Liu, M., Veenendaal, T., Kato, K., Liv, N., Klumperman, J., Collins, B. M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-50971-0 · Cited by 26
Genes Potentially Associated with Familial Hypercholesterolemia
Михайлова, С. В., Иванощук, Д. Е., Тимощенко, О. В., & Шахтшнейдер, Е. В. (2019) · Biomolecules · doi:10.3390/biom9120807 · Cited by 25
Lin, C., Jans, A., Wolters, J. C., Mohamed, M. R., van der Vorst, E. P. C., Trautwein, C., & Bartneck, M. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202202670 · Cited by 25
Self-citationRimbert, A., Dalila, N., Wolters, J. C., Huijkman, N., Smit, M., Kloosterhuis, N., Riemsma, M., van der Veen, Y., Singla, A., van Dijk, F., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz727 · Cited by 24
Self-citationPosttranscriptional regulation of the human LDL receptor by the U2-Spliceosome
Zanoni, P., Panteloglou, G., Othman, A., Haas, J. T., Meier, R., Rimbert, A., Futema, M., Abou Khalil, Y., Norrelykke, S. F., Rzepiela, A. J., et al. (2022) · Circulation Research · doi:10.1161/circresaha.120.318141 · Cited by 27
Self-citationJacques, M., Landen, S., Alvarez‐Romero, J., Hiam, D., Schittenhelm, R. B., Hanchapola, I., Shah, A. D., Voisin, S. A. C., & Eynon, N. (2023) · The FASEB Journal · doi:10.1096/fj.202300840rr · Cited by 22
Zwol, W. H.-V., Rimbert, A., Wolters, J. C., Smit, M., Bloks, V. W., Kloosterhuis, N., Huijkman, N., Koster, M. H., Tharehalli, U., Neck, S. D., et al. (2022) · Hepatology · doi:10.1002/hep.32709 · Cited by 21
Self-citationCommander Complex—A Multifaceted Operator in Intracellular Signaling and Cargo
Laulumaa, S., & Varjosalo, M. T. (2021) · Cells · doi:10.3390/cells10123447 · Cited by 21
Sorting nexin-27 regulates AMPA receptor trafficking through the synaptic adhesion protein LRFN2
McMillan, K. J., Banks, P. J., Hellel, F. L., Carmichael, R. E., Clairfeuille, T., Evans, A. J., Heesom, K. J., Lewis, P., Collins, B. M., Bashir, Z. I., et al. (2021) · eLife · doi:10.7554/elife.59432 · Cited by 21
Commander complex regulates lysosomal function and is implicated in Parkinson’s disease risk
Minakaki, G., Safren, N., Bustos, B. I., Lubbe, S. J., Mencacci, N. E., & Krainc, D. (2025) · Science · doi:10.1126/science.adq6650 · Cited by 19
Rutten, M. G. S., Derks, T. G. J., Huijkman, N., Bos, T., Kloosterhuis, N., van de Kolk, K. W. A., Wolters, J. C., Koster, M. H., Bongiovanni, L., Thomas, R., et al. (2021) · Hepatology · doi:10.1002/hep.32022 · Cited by 19
Self-citationClinical diversity and molecular mechanism of VPS35L-associated Ritscher-Schinzel syndrome
Otsuji, S., Nishio, Y., Tsujita, M., Rio, M., Huber, C., Antón-Plágaro, C., Mizuno, S., Kawano, Y., Miyatake, S., Simon, M., et al. (2023) · Journal of Medical Genetics · doi:10.1136/jmg-2022-108602 · Cited by 19
COMMD proteins function and their regulating roles in tumors
You, G., Chen, Z., Wang, L., Liu, Z., He, F., Yao, X., & Zhang, X. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1067234 · Cited by 19
Verkade, E., Shen, W., Hovingh, M. V., Mulder, N. L., de Bruyn, K., Koehorst, M., de Vries, H. D., Bloks, V. W., Kuipers, F., & de Boer, J. F. (2023) · Clinical Science · doi:10.1042/cs20230812 · Cited by 18
Vos, D. Y., Wijers, M., Smit, M., Huijkman, N., Kloosterhuis, N. J., Wolters, J. C., Tissink, J. J., Pronk, A. C. M., Kooijman, S., Rensen, P. C. N., et al. (2023) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.122.318169 · Cited by 16
Self-citationSystematic elucidation of genetic mechanisms underlying cholesterol uptake
Hamilton, M. C., Fife, J. D., Akinci, E., Yu, T., Khowpinitchai, B., Cha, M., Barkal, S., Thi, T. T., Yeo, G. H. T., Ramos Barroso, J. P., et al. (2023) · Cell Genomics · doi:10.1016/j.xgen.2023.100304 · Cited by 16
F-Actin Dynamics in the Regulation of Endosomal Recycling and Immune Synapse Assembly
Capitani, N., & Baldari, C. T. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.670882 · Cited by 16
Woerkom, A. V., Harney, D., Nagarajan, S. R., Hakeem-Sanni, M. F., Lin, J., Hooke, M., Pulpitel, T., Cooney, G. J., Larance, M., Saunders, D. N., et al. (2024) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00013.2024 · Cited by 15
Martens, N., Zhan, N., Yam, S. C., Leijten, F. P. J., Palumbo, M., Caspers, M. P. M., Tiane, A., Friedrichs, S., Li, Y., der Zee, L. V. V., et al. (2024) · Nutrients · doi:10.3390/nu16111614 · Cited by 15
Kane, J., Jansen, M. F., Hendrix, S., Bosmans, L. A., Beckers, L., van Tiel, C. M., Gijbels, M. J., Zelcer, N., de Vries, C. J. M., von Hundelshausen, P., et al. (2021) · Thrombosis and Haemostasis · doi:10.1055/a-1711-1055 · Cited by 14
The LDL receptor: Traffic and function in trophoblast cells under normal and pathological conditions
Aguilera-Olguín, M., & Leiva, A. (2022) · Placenta · doi:10.1016/j.placenta.2022.07.013 · Cited by 14
Shrestha, P., Yazdani, S., Vivès, R. R., Masri, R. E., Dam, W., van de Sluis, B., & van den Born, J. (2021) · Kidney International · doi:10.1016/j.kint.2021.01.023 · Cited by 13
Dietary supplements: clinical cholesterol-lowering efficacy and potential mechanisms of action
Ge, Q., Yue, Y., Luo, Y., Teng, T., Cao, C., Zhao, D., Zhang, J., Li, C., Chen, W., Yang, B., et al. (2024) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637486.2024.2342301 · Cited by 12
Disruption of COMMD1 accelerates diabetic atherosclerosis by promoting glycolysis
Zhang, L., Li, L., Li, Y., Jiang, H., Sun, Z., Zang, G., Qian, Y., Shao, C., & Wang, Z. (2023) · Diabetes and Vascular Disease Research · doi:10.1177/14791641231159009 · Cited by 12
Explosion in the complexity of membrane protein recycling
McDonald, F. J. (2021) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00171.2020 · Cited by 13
Ciavattone, N. G., Guan, N., Farfel, A. P., Stauff, J., Desmond, T. J., Viglianti, B. L., Scott, P. J. H., Brooks, A. F., & Luker, G. D. (2024) · JCI Insight · doi:10.1172/jci.insight.175320 · Cited by 10
Mak, M. C. E., Gurung, R., & Foo, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814057 · Cited by 10
CRISPR: a promising tool for lipid physiology and therapeutics
Furgurson, M. N., & Lagor, W. R. (2019) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000591 · Cited by 10
Fibroblast-derived osteoglycin promotes epithelial cell repair
van der Koog, L., Woest, M. E., Gorter, I. C., Verschut, V., Elferink, R. A. B., Zuidhof, A. B., Nugraha, D. F., Ngassie, M. L. K., Bos, S. T., Dhakad, D., et al. (2025) · npj Regenerative Medicine · doi:10.1038/s41536-025-00404-3 · Cited by 9
Self-citationAnti-ATR001 monoclonal antibody ameliorates atherosclerosis through beta-arrestin2 pathway
Wang, Y., Fan, Z., Xu, C., Yan, X., Zhou, Y., Qiu, Z., Yuan, Q., Zheng, J., Liao, Y., & Chen, X. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.01.054 · Cited by 9
Potential Roles of SNX17, Rab11, and Rab5 in LDLR Recycling
Zhao, X., Long, S., Zhu, M., Hao, H., Liao, Y., Zhang, C., & Liu, Z. (2025) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.125.322498 · Cited by 8
Tai, P., Wang, Z., Chen, X., Chen, A., Gong, L., Cheng, Y., & Cao, K. (2022) · Cancer Medicine · doi:10.1002/cam4.5320 · Cited by 8
Peritoneal Dialysis Aggravates and Accelerates Atherosclerosis in Uremic ApoE −/− Mice
Kane, J., Vos, W. G., Bosmans, L. A., van Os, B. W., den Toom, M., Hoeksema‐Hackmann, S., Wit, D. M., Gijbels, M. J., Beckers, L., Grefhorst, A., et al. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.034066 · Cited by 8
Self-citationFang, Q., Xue, Y., Yao, T., Liu, X., Chen, J., Han, Q., & Wang, X. (2024) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2024.109780 · Cited by 8
Yang, L., Fye, M. A., Yang, B., Tang, Z., Zhang, Y., Haigh, S., Covington, B. A., Bracey, K. M., Taraska, J. W., Kaverina, I., et al. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101541 · Cited by 8
Recycling the LDL receptor to combat atherosclerosis
Vos, D. Y., Kuivenhoven, J. A., & van de Sluis, B. (2018) · Aging · doi:10.18632/aging.101681 · Cited by 8
Self-citationGenome Editing in Dyslipidemia and Atherosclerosis
Chen, Z., Lehertshuber, C., & Schunkert, H. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-981-19-5642-3_10 · Cited by 7
Martens, N., Zhan, N., Yam, S. C., Palumbo, M., Pontini, L., Leijten, F. P. J., der Zee, L. V. V., Voortman, G. J., Friedrichs, S., Gerding, A., et al. (2025) · British Journal of Pharmacology · doi:10.1111/bph.70031 · Cited by 7
van Os, B. W., Vos, W. G., Bosmans, L. A., van Tiel, C. M., de Vries, C. J. M., den Toom, M., Beckers, L., Levels, J. H. M., van Wouw, S. A. E., Zelcer, N., et al. (2023) · European Heart Journal Open · doi:10.1093/ehjopen/oead013 · Cited by 7
Self-citationVerzijl, C. R. C., van de Peppel, I. P., Eilers, R. E., Bloks, V. W., Wolters, J. C., Koehorst, M., Kloosterhuis, N., Havinga, R., Jalving, M., Struik, D., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114270 · Cited by 6
Self-citationInitial proteomic characterization of IMMODIN, commercially available dialysable leukocytes extract
Zúñiga-Navarrete, F., Zavala-Meneses, S. G., Zelnı́k, V., Kopáček, J., & Škultéty, Ľ. (2021) · Chemical Papers · doi:10.1007/s11696-020-01467-w · Cited by 6
He, J., Ma, H., Jiang, D., Wang, T., Li, Z., Shi, G., Hong, Y., Zhu, C., & Li, G. (2025) · Fishes · doi:10.3390/fishes10030128 · Cited by 5
COMMD3-Mediated Endosomal Trafficking of HER2 Inhibits the Progression of Ovarian Carcinoma
Wang, S., Liu, Y., Li, S., Chen, Y., Liu, Y., Yan, J., Wu, J., Li, J., Wang, L., Xiang, R., et al. (2022) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-22-0333 · Cited by 5
Fang, X., Wang, X., Hao, M., Zhong, G., Gao, M., Pan, Y., Pan, Y., Yang, H., Yin, X., Shen, J., et al. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177649 · Cited by 5
Novel therapeutic targets for atherosclerosis: Targeting the FOSB-MECP2-Commd1 pathway
Fu, X., Xu, Z., Yang, T., Chen, J., & Niu, T. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113575 · Cited by 3
Enrich, C., Lu, A., Tebar, F., Rentero, C., & Grewal, T. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-21547-6_15 · Cited by 3
LDL receptor traffic: in the fast lane
Kleber, M. E., Delgado, G. E., & März, W. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz866 · Cited by 3
Xu, J.-J., Yu, C., Zhou, X., Liu, Y., Zhang, Y., Dai, X., & Wang, J. (2025) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5c00014 · Cited by 2
Jiang, S., Leng, P., Li, Y., Song, L., Xu, X., & Yang, L. (2026) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-026-05655-4 · Cited by 2
Chemoattractant receptor signaling in humoral immunity
Shirai, T., Nakai, A., & Suzuki, K. (2024) · International Immunology · doi:10.1093/intimm/dxae021 · Cited by 2
The CCC Complex COMManDs Control of LDL Cholesterol Levels
Keating, M. F., & Calkin, A. C. (2018) · Circulation Research · doi:10.1161/circresaha.118.313074 · Cited by 2
RNF130 Adds Further Complexity to the Regulation of LDL Receptor Activity
Robert, J., Panteloglou, G., & von Eckardstein, A. (2023) · Circulation Research · doi:10.1161/circresaha.123.322555 · Cited by 2
Kumar, N., Yang, M.-L., Sun, P., Hunker, K. L., Li, J., Jia, J., Fan, F., Wang, J., Ning, X., Gao, W., et al. (2024) · PLOS Genetics · doi:10.1371/journal.pgen.1011151 · Cited by 1
Heida, A., van Dijk, T. H., Smit, M., Koehorst, M., Koster, M. H., Kloosterhuis, N., Havinga, R., Bloks, V. W., Wolters, J. C., de Bruin, A., et al. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2023.159445 · Cited by 1
Self-citationCOPI Coatomer Regulates Several Steps of HDL Metabolism
Panteloglou, G., Zanoni, P., Law, C. S., Woods, B., Othman, A., Yalçınkaya, M., Nørrelykke, S. F., Rzepiela, A. J., Stoma, S., Stebler, M., et al. (2026) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.126.324616 · Cited by 1
Self-citationPalma-Cobo, M., Toribio, V., Morales, J., López‐Martín, S., Enrich, C., Lu, A., & Yáñez‐Mó, M. (2025) · Journal of Extracellular Vesicles · doi:10.1002/jev2.70166 · Cited by 1
Metadata
- Authors
- Fedoseienko, A., Wijers, M., Wolters, J. C., Dekker, D., Smit, M., Huijkman, N., Kloosterhuis, N., Klug, H., Schepers, A., Willems van Dijk, K., Levels, J. H. M., Billadeau, D. D., Hofker, M. H., van Deursen, J., Westerterp, M., Burstein, E., Kuivenhoven, J. A., & van de Sluis, B.
- Affiliations
- From the Molecular Genetics Section, Department of Pediatrics (A.F., M. Wijers, J.C.W., D.D., M.S., N.H., N.K., M.H.H., M. Westerterp, J.A.K., B.v.d.S)
- University Medical Center Groningen (NL)
- Helmholtz Munich (DE)
- Department of Human Genetics (K.W.v.D.) and Department of Medicine (K.W.v.D.)
- Leiden University Medical Center (NL)
- Division of Oncology Research, Department of Immunology and Biochemistry (D.D.B.)
- Mayo Clinic (US)
- Corresponding author
- Fedoseienko, Alina
- Wijers, Melinde
- Hofker, Marten H.
- ORCID
- Venue
- Circulation Research
- Published
- 2018-06-08
- Volume
- 122
- Issue
- 12
- Pages
- 1648-1660
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2789459269
- Semantic Scholar
- a85c0318e11c0e80da25385a3262f6b70ce81412
- Cited by
- 126
- References
- 41
- Citations by year
- 2026: 10 · 2025: 16 · 2024: 20 · 2023: 18 · 2022: 11 · 2021: 21 · 2020: 9 · 2019: 16 · 2018: 5
- FWCI
- 5.56
- Type
- journal article
- Language
- en
- Open access
- green
- pure.amsterdamumc.nl
- Licence
- other-oa
- Locations
- Circulation Research (publishedVersion)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion)
- Pure Amsterdam UMC (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Funders
- Jan Kornelis de Cock Stichting
- Rijksuniversiteit Groningen
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Keywords
- COMMD1, LDL receptor, LRP1, plasma LDL cholesterol, hypercholesterolemia, atherosclerosis, dyslipidemia, hepatic lipid metabolism
- MeSH terms
- Animals, Carrier Proteins, Cell Line, Cholesterol, Chromatography, High Pressure Liquid, Cytoskeletal Proteins, Humans, Cholesterol, LDL, Liver, Male, Receptors, LDL, Endosomes, Triglycerides, Gene Expression, Gene Deletion, Mice, Knockout, Protein Transport, Tumor Suppressor Proteins, Low Density Lipoprotein Receptor-Related Protein-1, Adaptor Proteins, Signal Transducing, Atherosclerosis, Mice, Hep G2 Cells, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-08, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-08 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review